Eulerpool Data & Analytics INHIBIKASE THERAPEUTICS, INC. WILMINGTON, US-DE
Name
INHIBIKASE THERAPEUTICS, INC.
Adresse
INHIBIKASE THERAPEUTICS, INC.
c/o PHS CORPORATE SERVICES
INC.
1313 N MARKET ST STE 5100
19801 WILMINGTON
Hauptsitz
3350 Riverwood Parkway Southeast; Suite 1900, 30339 Atlanta
Legal Entity Identifier (LEI)
549300066CFEWOA17F12
Legal Operating Unit (LOU)
5299000J2N45DDNE4Y28
Handelsregister
4832244
Rechtsform
XTIQ
Unternehmenskategorie
Allgemein
Status
Ausgestellt
Validierungsstatus
Voll bekräftigt
Zuletzt aktualisiert
29.8.2023
Nächste Erneuerung
29.8.2024
Eulerpool API INHIBIKASE THERAPEUTICS, INC. Umsatz, Gewinn, Bilanz, Patente, Mitarbeiter und mehr WILMINGTON, US-DE
{
"lei": "549300066CFEWOA17F12",
"legal_jurisdiction": "US-DE",
"legal_name": "INHIBIKASE THERAPEUTICS, INC.",
"entity_category": "GENERAL",
"entity_legal_form_code": "XTIQ",
"legal_first_address_line": "c/o PHS CORPORATE SERVICES, INC., 1313 N MARKET ST STE 5100",
"legal_additional_address_line": "",
"legal_city": "WILMINGTON",
"legal_postal_code": "19801",
"headquarters_first_address_line": "3350 Riverwood Parkway Southeast; Suite 1900",
"headquarters_additional_address_line": "",
"headquarters_city": "Atlanta",
"headquarters_postal_code": "30339",
"registration_authority_entity_id": "4832244",
"next_renewal_date": "2024-08-29T13:00:07.000Z",
"last_update_date": "2023-08-29T13:00:07.000Z",
"managing_lou": "5299000J2N45DDNE4Y28",
"registration_status": "ISSUED",
"validation_sources": "FULLY_CORROBORATED",
"reporting_exception": "",
"slug": "INHIBIKASE THERAPEUTICS, INC.,WILMINGTON,4832244"
}Andere Unternehmen in derselben Gerichtsbarkeit